American Assets Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

American Assets Investment Management, LLC

$1.12 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$177.01 - $223.45 $3.54 Million - $4.47 Million	-20,000 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $2.07 Million - $2.41 Million	10,000 Added 100.0%	20,000 $4.3 Million
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $2.07 Million - $2.76 Million	10,000 New	10,000 $2.36 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.9 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.45 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.82 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.67 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Assets Investment Management, LLC with notifications on news.

Account